What are the possible reasons for why Samumed is doing the supplemental phase 2 for SM04554?
I see 2 possibilities:
1. The drug did not grow hair in the original phase 2 so they want to dig into the skin with biopsies to find out why?
2. The drug did grow hair so Samumed wants to collect as much data as possible to give to the FDA to increase the likelihood of the drug being approved. And Samumed may even be hoping that the FDA will allow the drug to come to market after completing phase 2 if the new 20th Century Cures Act passes and if Samumed can give the FDA enough info to satisfy the FDA by doing a detailed supplemental phase 2 with biopsies.
I see 2 possibilities:
1. The drug did not grow hair in the original phase 2 so they want to dig into the skin with biopsies to find out why?
2. The drug did grow hair so Samumed wants to collect as much data as possible to give to the FDA to increase the likelihood of the drug being approved. And Samumed may even be hoping that the FDA will allow the drug to come to market after completing phase 2 if the new 20th Century Cures Act passes and if Samumed can give the FDA enough info to satisfy the FDA by doing a detailed supplemental phase 2 with biopsies.
Comment